NCT03477279

Brief Summary

There is promising evidence that couple-based approaches within Malawi's Option B+ prevention of mother to child transmission program could address help address 1) poor male engagement in the HIV continuum of care, 2) low male adoption of biomedical HIV prevention approaches, 3) sub-optimal female engagement in the continuum of care, and 4) poor or uncertain infant outcomes. Our team has developed an intervention to address these challenges, and will conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at one year. Women with recent HIV infections enrolled in this trial will be compared against a cohort of 350 HIV-uninfected women to explore predictors of HIV acquisition in pregnancy in Malawi.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,116

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
9 months until next milestone

Results Posted

Study results publicly available

June 24, 2021

Completed
Last Updated

June 24, 2021

Status Verified

March 1, 2021

Enrollment Period

2.8 years

First QC Date

March 19, 2018

Results QC Date

April 30, 2021

Last Update Submit

June 3, 2021

Conditions

Keywords

couple HIV testing and counselingdisclosureMalawi

Outcome Measures

Primary Outcomes (6)

  • Number of Women Retained in Care

    Women who presented at 12 months and reported taking at least one dose of ART in the last seven days

    12 months

  • Number of Women With Viral Suppression

    Women who presented at 12 months with a viral load \<1000 copies/mL

    12 months

  • Number of HIV-positive Male Partners Aware of Their HIV-positive Status

    HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit

    12 months

  • Number of HIV-positive Male Partners Retained in Care

    HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days

    12 months

  • Number of HIV-positive Male Partners With Viral Suppression

    HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL

    12 months

  • Number of HIV-negative Men Without HIV Exposure From Their Primary Partner

    HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner

    12 months

Secondary Outcomes (2)

  • Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis

    12 months

  • Predictors of Recent HIV Infection

    At the day of female consent

Study Arms (3)

Individual (SOC)

NO INTERVENTION

HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.

Couple (Intervention)

EXPERIMENTAL

In addition to receiving standard of care procedures, HIV-infected pregnant women in the couple arm will be provided with an intervention aimed at recruiting their male partners, providing enhanced couple counseling and testing, engaging their male partners in their care, and supporting male partners to receive care and treatment services.

Behavioral: Enhanced Couple HIV Testing and Counseling

HIV-Uninfected Cohort

NO INTERVENTION

HIV-uninfected pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.

Interventions

Participants are provided study-specific partner referral cards and encouraged to bring male partners to antenatal care for a male engagement intervention. Those who do not present on their own are then traced. Couples will receive three enhanced couple counseling sessions that include: pre-test counseling, return of joint results, and post-test counseling. HIV-infected men will be able to initiate cART at the antenatal clinic and the couple will be offered condoms from the HTC counselor. Between sessions, couple members can pick up condoms and cART for one another.

Also known as: male engagement intervention
Couple (Intervention)

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-infected and eligible for Option B+
  • \>18 years old or 15-17 years old and married
  • Planning to remain in the Bwaila catchment area for the next year or notify the study team if they leave the area or change facilities
  • Part of a heterosexual relationship for \>3 months
  • Expects the partner to be in the relevant catchment area for at least one week in the next six months.
  • Able and willing to give locator information for this partner
  • Willing to have study staff conduct phone and physical tracing of that partner
  • Willing to undergo a couple-based intervention with this partner
  • Able and willing to provide informed consent
  • \>18 years old or 15-17 years old and married
  • In a relationship with the female partner for \>3 months
  • Willing to undergo a couples-based intervention with their female partner
  • Able and willing to provide informed consent
  • HIV-uninfected
  • \>18 years old or 15-17 years old and married
  • +4 more criteria

You may not qualify if:

  • Any condition that in the opinion of the study investigator would compromise the ability of the prospective participant to provide informed consent, undergo study procedures safely, or would prevent proper conduct of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bwaila District Hospital Antenatal Unit

Lilongwe, Central District, Malawi

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

Counseling

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Nora Rosenberg, PhD, MSPH
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Nora E Rosenberg, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

March 26, 2018

Study Start

September 25, 2017

Primary Completion

July 21, 2020

Study Completion

September 30, 2020

Last Updated

June 24, 2021

Results First Posted

June 24, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations